Gary B. Sherrill

Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer

Beth Van Emburgh, Jennifer J. Hu, Edward A. Levine et al. · Oncology Reports · 2008 · 45 citations · Full text

Medicine, Genetics, Oncology +9

A Community-Based Multicenter Trial of Pharmacokinetically Guided 5-Fluorouracil Dosing for Personalized Colorectal Cancer Therapy

Jai N. Patel, Bert H. O’Neil, Allison M. Deal et al. · The Oncologist · 2014 · 44 citations · Full text

Medicine, Oncology, Pharmacology +17

Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay

Katherine Clifton, Thereasa A. Rich, Christine M. Parseghian et al. · JCO Precision Oncology · 2019 · 43 citations · Full text

Medicine, Molecular Biology, Oncology +17

Multicenter, randomized, double‐blind phase 2 trial of <scp>FOLFIRI</scp> with regorafenib or placebo as second‐line therapy for metastatic colorectal cancer

Hanna K. Sanoff, Richard M. Goldberg, Anastasia Ivanova et al. · Cancer · 2018 · 37 citations · Full text

Medicine, Oncology, Pharmacology +12

Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer.

D Fisher, Gary B. Sherrill, A Hussein et al. · PubMed · 1996 · 26 citations

Medicine, Hematology, Oncology +8